Adaptive focused radiation for belly and pelvic cancer spread
Part of Cancer, Digestive system clinical trials.
This Phase 1 study tests an “adaptive” form of focused radiation (SBRT) for cancers that have spread in the abdomen or pelvis. It aims to treat metastatic tumor spots safely while adjusting the plan as needed during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (age 18 or older) with confirmed cancer that has spread to the abdomen or pelvis
- You have at least one measurable tumor spot in the abdomen/pelvis that has not been treated with radiation or other procedures and is suitable for imaging measurement
- Your overall health is good: you’re able to do daily activities (ECOG 0 or 1) and you’re expected to live at least 12 months
- Your blood and organ tests are strong enough (white blood cells, platelets, liver tests, and kidney function meet set limits)
- You can sign consent forms and share information for the study (translation help is available if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of radiation that adjusts to changes in your prostate during treatment. It aims to improve accuracy and reduce side effects for men with intermediate- or high-risk prostate cancer.
This trial is testing a precise type of radiation therapy (called SBRT) for people with sarcoma in the belly or pelvic area. The goal is to see if this targeted radiation can help shrink or control the tumor before surgery, and it may be an option if you haven't had radiation to that area before.
This trial tests a new way to give radiation therapy for tumors in the belly or pelvis. Doctors will use daily MRI scans to adjust the radiation dose, aiming to better protect nearby organs while still treating the cancer.
This trial tests a new way to deliver targeted radiation for cancer that has spread to lymph nodes in the belly or pelvis. The radiation dose is adjusted during each session to better hit the tumor while protecting healthy tissue.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
This trial tests targeted radiation (SBRT) for people whose rectal cancer has come back in the pelvis and cannot be surgically removed. The goal is to see if this focused radiation can control the tumor with fewer side effects.
Hear when a new Neoplasm - Soft Tissue Pelvis Malignant Secondary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.